Oslo, 20 May 2021: In connection with the annual general meeting of Observe
Medical ASA (the "Company") to be held on 21 May 2021 (the "AGM"), Terje Bakken,
chairman of the board of directors of the Company, has as at the close of
trading on the Oslo Stock Exchange on 20 May 2021, received proxies without
voting instructions for 1,576,864 shares or 8.04% of the total shares and voting
rights in the Company. The proxies are only valid at the AGM.
In addition, Terje Bakken represents Ingerø Reiten Investment Company AS at the
board of directors of the Company, who holds 3,939,394 shares or 20.09% of the
total shares and voting rights in the Company. Hence, following the receipt of
the proxy, Terje Bakken controls 28.14% of the total shares and voting rights in
the Company at the AGM.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.